SPARK NS Translational Research Program, 2027 Cohort | SPARK NS | DEADLINE June 5
What: Mentorship & Funding
When: 2027
Where: Hybrid
Info:
SPARK NS is now accepting applications from academic researchers developing therapeutics for autism and Parkinson's disease for the 2027 Cohort of our translational research program. Selected projects will receive milestone-based funding of up to $2,000,0001 and extensive support in all aspects of translational research and drug development.
This program welcomes PIs with projects focused on developing therapeutics for autism, Parkinson’s disease, and adjacent disorders at academic or nonprofit research institutions in the US, Canada, the UK, and Europe.
Optional Pre-Submission Review Deadline: May 12, 5 PM PT.
More info, and application: